Hi, along with others, I have ran a study to determine if the disclosure of genotype (risk/non-risk) impacts adherence to dietary recommendations for the reduction of salt. We have collected a lot of data on subjects including: anthropometric, inter-arm difference and average blood pressure, genotype, assessed genetic understanding and attitudes, and assessed dietary salt intake by dietary recalls and 24-h urine collections pre-disclosure and 4-weeks after. We determined ‘adherence’ as a greater reduction in dietary salt after 4-weeks.
I was convinced the statistical tests we would use would be a manova, however the majority of the variables mentioned above are abnormally distributed (Shapiro-Wilk, univariate test of normality).
Although, another question on here indicated that univariate tests of normality may not be applicable when using them in a manova.
Secondly, I came across a question where someone suggested if the abnormal distribution did impact the manova a Munzel-brunner method in comparison to the Friedman’s two-way anova would be the better option.
I am looking for opinions/recommendations as to my next steps as I have very limited statistical knowledge.
Thanks in advance.